Emanuela Romano

6.9k citations

65 papers · 4.0k indexed · 5 hit papers · h-index 29

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management

Papers in

Oncology 50
- Cancer Immunotherapy and Biomarkers 34
- CAR-T cell therapy research 14
- Cancer Cells and Metastasis 4
Immunology 33
- Immunotherapy and Immune Responses 20
- Immune Cell Function and Interaction 12
- Immune cells in cancer 6
- T-cell and B-cell Immunology 5

Co-authors: Daniel E. Speiser Olivier Michielin Petra Baumgaertner Christiane Meyer Pedro Romero Martine Piccart Laurène Cagnon Paul B. Chapman
Journals: Annals of Oncology (6 papers)Journal of Clinical Oncology (6 papers)Clinical Cancer Research (5 papers)Journal of Translational Medicine (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
Partner nations: France United States Switzerland

In The Last Decade

Emanuela Romano

63 papers receiving 4.0k citations

Hit Papers

5 papers align trajectories log scale

Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer 2024 · 57 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Communications
2023 npj Breast Cancer
2022 Cancer Research
2015 Proceedings of the National Academy of Sciences
2013 Cancer Immunology Immunotherapy

Peers

Countries citing papers authored by Emanuela Romano

Since Specialization

Citations

This map shows the geographic impact of Emanuela Romano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Romano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Romano more than expected).

Fields of papers citing papers by Emanuela Romano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Romano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Romano. The network helps show where Emanuela Romano may publish in the future.

Co-authors

The 25 scholars most cited alongside Emanuela Romano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emanuela Romano Line = papers co-authored together Emanuela Romano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Predicting axillary residual disease after neoadjuvant therapy in breast cancer using baseline MRI and ultrasound European Radiology ·Caroline Malhaire, Alexandre Kauskot, Vincent Cockenpot, Pamela Theus, Toulsie Ramtohul, Fabien Reyal, Jean‐Yves Pierga, Emanuela Romano, Anne Vincent‐Salomon, Youlia Kirova, Enora Laas, Hervé J. Brisse, Frédérique Frouin	2025	0
2	Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial Radiotherapy and Oncology ·Alex De Caluwé, S. A. Martin, Kim Cao, Paweł Pijarski, Vincent Remouchamps, 范卫平, Henrike Böhme, Igor Bessières, Giovanni de Macque, Lifang Chen, Dirk Van Gestel, Isabelle Desmoulins, Michail Ignatiadis, Emanuela Romano, Laurence Buisseret, Martine Piccart, Alexey Korepanov, Ákos Gulybán, Philip Poortmans	2025	2
3	Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas Clinical Cancer Research ·Kevin J. Harrington, Stéphane Champiat, Joshua Brody, Byoung Chul Cho, Emanuela Romano, Talia Golan, John Hyngstrom, James Strauss, David Y. Oh, Aron Popovtzer, Carlos Gomez‐Roca, Ruth Perets, Sung‐Bae Kim, Deborah J. Wong, Steven Powell, Anuradha Khilnani, Thomas Jemielita, D. Barry Starr, Runchen Zhao, Matthew Ingham	2025	10
4	2O TILs and PD-L1 early dynamics in the randomized Neo-CheckRay phase II trial evaluating neo-adjuvant immuno-radiation and adenosine pathway blockade for early-stage, high risk ER+/HER2- breast cancer (BC) Immuno-Oncology Technology ·川水, Graziella Tendron, Arantza Cerón-Muñiz, Gan Nai-feng, Isabelle Desmoulins, Emanuela Romano, Vincent Remouchamps, Armstrong Jean-Paul, DU Qing-jin, Cédric van Marcke, Houwing Frank, Michail Ignatiadis, Martine Piccart, Denis Larsimont, John Stagg, Christos Sotiriou, Roberto Salgado, Laurence Buisseret	2024	0
5	319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC) Annals of Oncology ·Estelle Bastien, Sonal Kalra, Feby Tiara Noor Kharisma, Milica Marić Stojanović, Delphine Loirat, Marie‐Paule Sablin, Anne Vincent‐Salomon, Sun Yao-zhu, Marcello Venturi, Caroline Malhaire, Alexia Savignoni, Emanuela Romano	2024	1
6	Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer Nature Communications ·de Nicolai A, Rana Mhaidly, Yann Kieffer, Géraldine Gentric, Lounes Djerroudi, Renaud Leclère, Floriane Pelon, Phillip Hoffarth, Mylène Bohec, Yasmin Córdoba Sánchez, Didier Meseure, Emanuela Romano, Sylvain Baulande, Agathe Peltier, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou Hit paper breakdown →	2024	57
7	Use of Pretreatment Perfusion MRI–based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy Radiology ·Toulsie Ramtohul, Paola Nix, Claire Bonneau, Jamila Demirova, Emmanuelle Menet, Mayuka Hasumi, Enora Laas, Emanuela Romano, Asim Zulfiqar, М.А. КОЖУШНЕР, Anne Vincent‐Salomon, François‐Clément Bidard, A. Langer, Caroline Malhaire, Luc Cabel, Hervé J. Brisse, A. Tardivon	2024	14
8	Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases British Journal of Cancer ·Pascale Mariani, Stephen Parker, Steven Van Laere, Peter Vermeulen, Leanne de Koning, Sergio Roman‐Roman, Olivier Lantz, Manuel Rodrigues, Marc‐Henri Stern, Sophie Gardrat, Laëtitia Lesage, Gabriel Champenois, Nicolás André, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Emanuela Romano, Sophie Piperno‐Neumann, Claire Lugassy, Raymond L. Barnhill	2023	8
9	Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer Cancer Research ·Eleonora Timperi, Paul Gueguen, Martina Molgora, Ilaria Magagna, Yann Kieffer, Zhao Ping, Philémon Sirven, Laura G. Baudrin, Sylvain Baulande, Nicolás André, Gabriel Champenois, Didier Meseure, Anne Vincent‐Salomon, A. Tardivon, Enora Laas, Vassili Soumelis, Marco Colonna, Fatima Mechta‐Grigoriou, Sebastián Amigorena, Emanuela Romano Hit paper breakdown →	2022	173
10	1567MO COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE) Annals of Oncology ·Emanuela Romano, Spyridon Gennatas, Jacobo Rogado, Marina Sekacheva, D. Viñal, Rebecca Lee, Yang Lei, Е.Н. Николаенко, Ranhel C. De Roxas-Bernardino, Sneẑana Šušnjar, Lin Yo-Sheng, F. A. Krupnov, Swanand Rishi, Bill Van Volkenburgh, Dirk Arnold, Kinue Yamamoto, Kevin J. Harrington, Olivier Michielin, George Pentheroudakis, Solange Peters	2021	1
11	Immunothérapie et cancer du poumon : nouveaux concepts Revue des Maladies Respiratoires ·Anne‐Gaëlle Goubet, Alain Livartowski, Emanuela Romano	2018	2
12	Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy Nature Reviews Clinical Oncology ·Luc Cabel, Charlotte Proudhon, Emanuela Romano, Nicolas Girard, Olivier Lantz, Marc‐Henri Stern, Jean‐Yves Pierga, François‐Clément Bidard	2018	151
13	Mechanisms of Resistance to Immune Checkpoint Antibodies Handbook of experimental pharmacology ·Rodrigo Nalio Ramos, Eliane Piaggio, Emanuela Romano	2017	24
14	Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights Cancer Treatment Reviews ·Gongda Xue, Emanuela Romano, Daniela Massi, Mario Mandalà	2016	83
15	Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial Clinical Cancer Research ·Amandine Legat, Hélène Maby–El Hajjami, Petra Baumgaertner, Laurène Cagnon, Samia Abed Maillard, Christine Geldhof, Emanuela M. Iancu, Luc Lebon, Philippe Guillaume, Danijel Dojcinovic, Olivier Michielin, Emanuela Romano, Grégoire Berthod, Donata Rimoldi, Frédéric Triebel, Immanuel F. Luescher, Nathalie Rufer, Daniel E. Speiser	2015	76
16	Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response Science Translational Medicine ·Pia Kvistborg, Daisy Philips, Sander Kelderman, Lois Hageman, Christian H. Ottensmeier, Deborah Joseph-Pietras, Marij J.P. Welters, Sjoerd van der Burg, Ellen Kapiteijn, Olivier Michielin, Emanuela Romano, Carsten Linnemann, Daniel E. Speiser, Christian U. Blank, John B.A.G. Haanen, Ton N. Schumacher	2014	288
17	Phenotypic and Functional Activation of Hyporesponsive KIRnegNKG2Aneg Human NK-Cell Precursors Requires IL12p70 Provided by Poly(I:C)-Matured Monocyte-Derived Dendritic Cells Cancer Immunology Research ·Shane A. Curran, Emanuela Romano, Michael G. Kennedy, Katharine C. Hsu, James W. Young	2014	5
18	Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression Clinical Cancer Research ·Emanuela Romano, Sylvain Pradervand, Alexandra Paillusson, Johann Weber, Keith Harshman, Katja Muehlethaler, Daniel E. Speiser, Solange Peters, Donata Rimoldi, Olivier Michielin	2013	96
19	Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy Journal of Translational Medicine ·David J. Chung, Emanuela Romano, Miguel Lapo Palacios, Justin A. Shyer, Milena Mennecozzi, C. Quiles, James W. Young	2013	16
20	Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro , Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo Clinical Cancer Research ·Emanuela Romano, Marco Rossi, Gudrun Ratzinger, Héctor Leal Silva, David J. Chung, Katherine S. Panageas, P. Fabyan, Alan N. Houghton, Paul B. Chapman, Glenn Heller, Jianda Yuan, James W. Young	2011	61

About Emanuela Romano

Emanuela Romano is a scholar working on Oncology, Immunology, Cancer Research, Ophthalmology and Biological Psychiatry, having authored 65 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (34 papers), Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (12 papers), Melanoma and MAPK Pathways (7 papers), Immune cells in cancer (6 papers), T-cell and B-cell Immunology (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (2.7k citations), Cancer Research (587 citations), Biological Psychiatry (84 citations) and Molecular Biology (1.2k citations). Emanuela Romano has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Daniel E. Speiser, Olivier Michielin, Petra Baumgaertner, Christiane Meyer, Pedro Romero, Martine Piccart, Laurène Cagnon, Paul B. Chapman, Carla Costa-Nunes and Nicole Montandon. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Cancer Research, Journal of Translational Medicine and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact